Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does UBIDECARENONE Cause Intentional product use issue? 7 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Intentional product use issue have been filed in association with UBIDECARENONE (CO Q 10). This represents 1.9% of all adverse event reports for UBIDECARENONE.

7
Reports of Intentional product use issue with UBIDECARENONE
1.9%
of all UBIDECARENONE reports
0
Deaths
1
Hospitalizations

How Dangerous Is Intentional product use issue From UBIDECARENONE?

Of the 7 reports, 1 (14.3%) required hospitalization, and 1 (14.3%) were considered life-threatening.

Is Intentional product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for UBIDECARENONE. However, 7 reports have been filed with the FAERS database.

What Other Side Effects Does UBIDECARENONE Cause?

Drug ineffective (130) Headache (125) Pain (125) Malaise (115) Off label use (114) Nausea (113) Therapeutic product effect incomplete (113) Abdominal pain (109) Constipation (109) Pyrexia (109)

What Other Drugs Cause Intentional product use issue?

INFLIXIMAB (11,028) RITUXIMAB (9,602) INFLIXIMAB-DYYB (7,549) TOCILIZUMAB (5,078) METHOTREXATE (4,087) PREDNISONE (3,961) ABATACEPT (3,693) ADALIMUMAB (3,557) NIVOLUMAB (3,297) LEFLUNOMIDE (3,280)

Which UBIDECARENONE Alternatives Have Lower Intentional product use issue Risk?

UBIDECARENONE vs UBLITUXIMAB UBIDECARENONE vs UBLITUXIMAB-XIIY UBIDECARENONE vs UBROGEPANT UBIDECARENONE vs ULIPRISTAL UBIDECARENONE vs UMBRALISIB

Related Pages

UBIDECARENONE Full Profile All Intentional product use issue Reports All Drugs Causing Intentional product use issue UBIDECARENONE Demographics